Status:
COMPLETED
Customized Laser Ablation: Comparing Results of LADAR Vision and VISX Platforms
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Customized Laser Ablation
Eligibility:
All Genders
18-88 years
Brief Summary
To compare the results of two commercially available customized laser ablation devices.
Detailed Description
In the past few years, several custom laser ablation platforms have emerged in the marketplace but only two are currently approved by the FDA. They are the LADAR CustomLasik (Alcon: Ft. Worth, TX) and...
Eligibility Criteria
Inclusion
- Individuals of both genders, aged 18 and older, who have been scheduled to undergo customized laser ablation will be considered for this prospective study.
Exclusion
- There are no exclusion criteria available for this study.
Key Trial Info
Start Date :
September 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2017
Estimated Enrollment :
458 Patients enrolled
Trial Details
Trial ID
NCT00344838
Start Date
September 1 2003
End Date
October 30 2017
Last Update
January 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States, 75390-8866